ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Human Normal Immunoglobulin Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-29U7735
Home | Market Reports | Health| Pharmacy
Global Human Normal Immunoglobulin Market Insights and Forecast to 2028
BUY CHAPTERS

Global Human Normal Immunoglobulin Market Research Report 2025

Code: QYRE-Auto-29U7735
Report
July 2025
Pages:91
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
CSL Behring
Grifols S A
Biotest
Kedrion S p A
CBPO
Emergent (Cangene)
Kamada
CNBG
Hualan Bio
Shanghai Raas
Sichuan Yuanda Shuyang
ADMA Biologics

Human Normal Immunoglobulin Market

The global market for Human Normal Immunoglobulin was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Human normal immunoglobulin is a highly purified protein extracted from human plasma. It contains immunoglobulin G (IgG), which is a type of antibody that has been used as a medicine since the 1980s and has a wide range of activity against organisms that can cause infection. The normal range of IgG varies depending on age, with the IgG normal range for age 0-1 years being between 231-1411 mg/dL and the IgG normal range for age 10-11 years being between 698-1560 mg/dL.
North American market for Human Normal Immunoglobulin is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Human Normal Immunoglobulin is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Human Normal Immunoglobulin include CSL Behring, Grifols, Biotest, Kedrion, CBPO, Emergent (Cangene), Kamada, CNBG, Hualan Bio, Shanghai RAAS, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Human Normal Immunoglobulin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Normal Immunoglobulin.
The Human Normal Immunoglobulin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Normal Immunoglobulin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Normal Immunoglobulin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Human Normal Immunoglobulin Market Report

Report Metric Details
Report Name Human Normal Immunoglobulin Market
Segment by Type
Segment by Application
  • Government Institutions
  • Private Sector
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company CSL Behring, Grifols, Biotest, Kedrion, CBPO, Emergent (Cangene), Kamada, CNBG, Hualan Bio, Shanghai RAAS, Sichuan Yuanda Shuyang, ADMA Biologics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Human Normal Immunoglobulin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Human Normal Immunoglobulin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Human Normal Immunoglobulin Market report?

Ans: The main players in the Human Normal Immunoglobulin Market are CSL Behring, Grifols, Biotest, Kedrion, CBPO, Emergent (Cangene), Kamada, CNBG, Hualan Bio, Shanghai RAAS, Sichuan Yuanda Shuyang, ADMA Biologics

What are the Application segmentation covered in the Human Normal Immunoglobulin Market report?

Ans: The Applications covered in the Human Normal Immunoglobulin Market report are Government Institutions, Private Sector, Other

What are the Type segmentation covered in the Human Normal Immunoglobulin Market report?

Ans: The Types covered in the Human Normal Immunoglobulin Market report are Hepatitis B Immunoglobulins, Rabies Immunoglobulins, Tetanus Immunoglobulins, Others

Recommended Reports

Immunoglobulin Markets

Antibody Related

Immune Therapy & Diagnostics

1 Human Normal Immunoglobulin Market Overview
1.1 Product Definition
1.2 Human Normal Immunoglobulin by Type
1.2.1 Global Human Normal Immunoglobulin Market Value Comparison by Type (2024 VS 2031)
1.2.2 Hepatitis B Immunoglobulins
1.2.3 Rabies Immunoglobulins
1.2.4 Tetanus Immunoglobulins
1.2.5 Others
1.3 Human Normal Immunoglobulin by Application
1.3.1 Global Human Normal Immunoglobulin Market Value by Application (2024 VS 2031)
1.3.2 Government Institutions
1.3.3 Private Sector
1.3.4 Other
1.4 Global Human Normal Immunoglobulin Market Size Estimates and Forecasts
1.4.1 Global Human Normal Immunoglobulin Revenue 2020-2031
1.4.2 Global Human Normal Immunoglobulin Sales 2020-2031
1.4.3 Global Human Normal Immunoglobulin Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Human Normal Immunoglobulin Market Competition by Manufacturers
2.1 Global Human Normal Immunoglobulin Sales Market Share by Manufacturers (2020-2025)
2.2 Global Human Normal Immunoglobulin Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Human Normal Immunoglobulin Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Human Normal Immunoglobulin, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Human Normal Immunoglobulin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Normal Immunoglobulin, Product Type & Application
2.7 Global Key Manufacturers of Human Normal Immunoglobulin, Date of Enter into This Industry
2.8 Global Human Normal Immunoglobulin Market Competitive Situation and Trends
2.8.1 Global Human Normal Immunoglobulin Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Human Normal Immunoglobulin Players Market Share by Revenue
2.8.3 Global Human Normal Immunoglobulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Human Normal Immunoglobulin Market Scenario by Region
3.1 Global Human Normal Immunoglobulin Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Human Normal Immunoglobulin Sales by Region: 2020-2031
3.2.1 Global Human Normal Immunoglobulin Sales by Region: 2020-2025
3.2.2 Global Human Normal Immunoglobulin Sales by Region: 2026-2031
3.3 Global Human Normal Immunoglobulin Revenue by Region: 2020-2031
3.3.1 Global Human Normal Immunoglobulin Revenue by Region: 2020-2025
3.3.2 Global Human Normal Immunoglobulin Revenue by Region: 2026-2031
3.4 North America Human Normal Immunoglobulin Market Facts & Figures by Country
3.4.1 North America Human Normal Immunoglobulin Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Human Normal Immunoglobulin Sales by Country (2020-2031)
3.4.3 North America Human Normal Immunoglobulin Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Human Normal Immunoglobulin Market Facts & Figures by Country
3.5.1 Europe Human Normal Immunoglobulin Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Human Normal Immunoglobulin Sales by Country (2020-2031)
3.5.3 Europe Human Normal Immunoglobulin Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Normal Immunoglobulin Market Facts & Figures by Region
3.6.1 Asia Pacific Human Normal Immunoglobulin Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Human Normal Immunoglobulin Sales by Region (2020-2031)
3.6.3 Asia Pacific Human Normal Immunoglobulin Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Human Normal Immunoglobulin Market Facts & Figures by Country
3.7.1 Latin America Human Normal Immunoglobulin Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Human Normal Immunoglobulin Sales by Country (2020-2031)
3.7.3 Latin America Human Normal Immunoglobulin Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Normal Immunoglobulin Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Normal Immunoglobulin Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Human Normal Immunoglobulin Sales by Country (2020-2031)
3.8.3 Middle East and Africa Human Normal Immunoglobulin Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Human Normal Immunoglobulin Sales by Type (2020-2031)
4.1.1 Global Human Normal Immunoglobulin Sales by Type (2020-2025)
4.1.2 Global Human Normal Immunoglobulin Sales by Type (2026-2031)
4.1.3 Global Human Normal Immunoglobulin Sales Market Share by Type (2020-2031)
4.2 Global Human Normal Immunoglobulin Revenue by Type (2020-2031)
4.2.1 Global Human Normal Immunoglobulin Revenue by Type (2020-2025)
4.2.2 Global Human Normal Immunoglobulin Revenue by Type (2026-2031)
4.2.3 Global Human Normal Immunoglobulin Revenue Market Share by Type (2020-2031)
4.3 Global Human Normal Immunoglobulin Price by Type (2020-2031)
5 Segment by Application
5.1 Global Human Normal Immunoglobulin Sales by Application (2020-2031)
5.1.1 Global Human Normal Immunoglobulin Sales by Application (2020-2025)
5.1.2 Global Human Normal Immunoglobulin Sales by Application (2026-2031)
5.1.3 Global Human Normal Immunoglobulin Sales Market Share by Application (2020-2031)
5.2 Global Human Normal Immunoglobulin Revenue by Application (2020-2031)
5.2.1 Global Human Normal Immunoglobulin Revenue by Application (2020-2025)
5.2.2 Global Human Normal Immunoglobulin Revenue by Application (2026-2031)
5.2.3 Global Human Normal Immunoglobulin Revenue Market Share by Application (2020-2031)
5.3 Global Human Normal Immunoglobulin Price by Application (2020-2031)
6 Key Companies Profiled
6.1 CSL Behring
6.1.1 CSL Behring Company Information
6.1.2 CSL Behring Description and Business Overview
6.1.3 CSL Behring Human Normal Immunoglobulin Sales, Revenue and Gross Margin (2020-2025)
6.1.4 CSL Behring Human Normal Immunoglobulin Product Portfolio
6.1.5 CSL Behring Recent Developments/Updates
6.2 Grifols
6.2.1 Grifols Company Information
6.2.2 Grifols Description and Business Overview
6.2.3 Grifols Human Normal Immunoglobulin Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Grifols Human Normal Immunoglobulin Product Portfolio
6.2.5 Grifols Recent Developments/Updates
6.3 Biotest
6.3.1 Biotest Company Information
6.3.2 Biotest Description and Business Overview
6.3.3 Biotest Human Normal Immunoglobulin Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Biotest Human Normal Immunoglobulin Product Portfolio
6.3.5 Biotest Recent Developments/Updates
6.4 Kedrion
6.4.1 Kedrion Company Information
6.4.2 Kedrion Description and Business Overview
6.4.3 Kedrion Human Normal Immunoglobulin Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Kedrion Human Normal Immunoglobulin Product Portfolio
6.4.5 Kedrion Recent Developments/Updates
6.5 CBPO
6.5.1 CBPO Company Information
6.5.2 CBPO Description and Business Overview
6.5.3 CBPO Human Normal Immunoglobulin Sales, Revenue and Gross Margin (2020-2025)
6.5.4 CBPO Human Normal Immunoglobulin Product Portfolio
6.5.5 CBPO Recent Developments/Updates
6.6 Emergent (Cangene)
6.6.1 Emergent (Cangene) Company Information
6.6.2 Emergent (Cangene) Description and Business Overview
6.6.3 Emergent (Cangene) Human Normal Immunoglobulin Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Emergent (Cangene) Human Normal Immunoglobulin Product Portfolio
6.6.5 Emergent (Cangene) Recent Developments/Updates
6.7 Kamada
6.7.1 Kamada Company Information
6.7.2 Kamada Description and Business Overview
6.7.3 Kamada Human Normal Immunoglobulin Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Kamada Human Normal Immunoglobulin Product Portfolio
6.7.5 Kamada Recent Developments/Updates
6.8 CNBG
6.8.1 CNBG Company Information
6.8.2 CNBG Description and Business Overview
6.8.3 CNBG Human Normal Immunoglobulin Sales, Revenue and Gross Margin (2020-2025)
6.8.4 CNBG Human Normal Immunoglobulin Product Portfolio
6.8.5 CNBG Recent Developments/Updates
6.9 Hualan Bio
6.9.1 Hualan Bio Company Information
6.9.2 Hualan Bio Description and Business Overview
6.9.3 Hualan Bio Human Normal Immunoglobulin Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Hualan Bio Human Normal Immunoglobulin Product Portfolio
6.9.5 Hualan Bio Recent Developments/Updates
6.10 Shanghai RAAS
6.10.1 Shanghai RAAS Company Information
6.10.2 Shanghai RAAS Description and Business Overview
6.10.3 Shanghai RAAS Human Normal Immunoglobulin Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Shanghai RAAS Human Normal Immunoglobulin Product Portfolio
6.10.5 Shanghai RAAS Recent Developments/Updates
6.11 Sichuan Yuanda Shuyang
6.11.1 Sichuan Yuanda Shuyang Company Information
6.11.2 Sichuan Yuanda Shuyang Description and Business Overview
6.11.3 Sichuan Yuanda Shuyang Human Normal Immunoglobulin Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Sichuan Yuanda Shuyang Human Normal Immunoglobulin Product Portfolio
6.11.5 Sichuan Yuanda Shuyang Recent Developments/Updates
6.12 ADMA Biologics
6.12.1 ADMA Biologics Company Information
6.12.2 ADMA Biologics Description and Business Overview
6.12.3 ADMA Biologics Human Normal Immunoglobulin Sales, Revenue and Gross Margin (2020-2025)
6.12.4 ADMA Biologics Human Normal Immunoglobulin Product Portfolio
6.12.5 ADMA Biologics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Normal Immunoglobulin Industry Chain Analysis
7.2 Human Normal Immunoglobulin Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Normal Immunoglobulin Production Mode & Process Analysis
7.4 Human Normal Immunoglobulin Sales and Marketing
7.4.1 Human Normal Immunoglobulin Sales Channels
7.4.2 Human Normal Immunoglobulin Distributors
7.5 Human Normal Immunoglobulin Customer Analysis
8 Human Normal Immunoglobulin Market Dynamics
8.1 Human Normal Immunoglobulin Industry Trends
8.2 Human Normal Immunoglobulin Market Drivers
8.3 Human Normal Immunoglobulin Market Challenges
8.4 Human Normal Immunoglobulin Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
CSL Behring
Grifols S A
Biotest
Kedrion S p A
CBPO
Emergent (Cangene)
Kamada
CNBG
Hualan Bio
Shanghai Raas
Sichuan Yuanda Shuyang
ADMA Biologics
List of Tables
 Table 1. Global Human Normal Immunoglobulin Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Human Normal Immunoglobulin Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Human Normal Immunoglobulin Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Human Normal Immunoglobulin Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Human Normal Immunoglobulin Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Human Normal Immunoglobulin Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Human Normal Immunoglobulin Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Human Normal Immunoglobulin Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Human Normal Immunoglobulin, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Human Normal Immunoglobulin, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Human Normal Immunoglobulin, Product Type & Application
 Table 12. Global Key Manufacturers of Human Normal Immunoglobulin, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Human Normal Immunoglobulin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Normal Immunoglobulin as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Human Normal Immunoglobulin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Human Normal Immunoglobulin Sales by Region (2020-2025) & (K Units)
 Table 18. Global Human Normal Immunoglobulin Sales Market Share by Region (2020-2025)
 Table 19. Global Human Normal Immunoglobulin Sales by Region (2026-2031) & (K Units)
 Table 20. Global Human Normal Immunoglobulin Sales Market Share by Region (2026-2031)
 Table 21. Global Human Normal Immunoglobulin Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Human Normal Immunoglobulin Revenue Market Share by Region (2020-2025)
 Table 23. Global Human Normal Immunoglobulin Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Human Normal Immunoglobulin Revenue Market Share by Region (2026-2031)
 Table 25. North America Human Normal Immunoglobulin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Human Normal Immunoglobulin Sales by Country (2020-2025) & (K Units)
 Table 27. North America Human Normal Immunoglobulin Sales by Country (2026-2031) & (K Units)
 Table 28. North America Human Normal Immunoglobulin Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Human Normal Immunoglobulin Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Human Normal Immunoglobulin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Human Normal Immunoglobulin Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Human Normal Immunoglobulin Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Human Normal Immunoglobulin Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Human Normal Immunoglobulin Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Human Normal Immunoglobulin Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Human Normal Immunoglobulin Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Human Normal Immunoglobulin Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Human Normal Immunoglobulin Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Human Normal Immunoglobulin Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Human Normal Immunoglobulin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Human Normal Immunoglobulin Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Human Normal Immunoglobulin Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Human Normal Immunoglobulin Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Human Normal Immunoglobulin Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Human Normal Immunoglobulin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Human Normal Immunoglobulin Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Human Normal Immunoglobulin Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Human Normal Immunoglobulin Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Human Normal Immunoglobulin Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Human Normal Immunoglobulin Sales (K Units) by Type (2020-2025)
 Table 51. Global Human Normal Immunoglobulin Sales (K Units) by Type (2026-2031)
 Table 52. Global Human Normal Immunoglobulin Sales Market Share by Type (2020-2025)
 Table 53. Global Human Normal Immunoglobulin Sales Market Share by Type (2026-2031)
 Table 54. Global Human Normal Immunoglobulin Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Human Normal Immunoglobulin Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Human Normal Immunoglobulin Revenue Market Share by Type (2020-2025)
 Table 57. Global Human Normal Immunoglobulin Revenue Market Share by Type (2026-2031)
 Table 58. Global Human Normal Immunoglobulin Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Human Normal Immunoglobulin Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Human Normal Immunoglobulin Sales (K Units) by Application (2020-2025)
 Table 61. Global Human Normal Immunoglobulin Sales (K Units) by Application (2026-2031)
 Table 62. Global Human Normal Immunoglobulin Sales Market Share by Application (2020-2025)
 Table 63. Global Human Normal Immunoglobulin Sales Market Share by Application (2026-2031)
 Table 64. Global Human Normal Immunoglobulin Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Human Normal Immunoglobulin Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Human Normal Immunoglobulin Revenue Market Share by Application (2020-2025)
 Table 67. Global Human Normal Immunoglobulin Revenue Market Share by Application (2026-2031)
 Table 68. Global Human Normal Immunoglobulin Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Human Normal Immunoglobulin Price (US$/Unit) by Application (2026-2031)
 Table 70. CSL Behring Company Information
 Table 71. CSL Behring Description and Business Overview
 Table 72. CSL Behring Human Normal Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. CSL Behring Human Normal Immunoglobulin Product
 Table 74. CSL Behring Recent Developments/Updates
 Table 75. Grifols Company Information
 Table 76. Grifols Description and Business Overview
 Table 77. Grifols Human Normal Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Grifols Human Normal Immunoglobulin Product
 Table 79. Grifols Recent Developments/Updates
 Table 80. Biotest Company Information
 Table 81. Biotest Description and Business Overview
 Table 82. Biotest Human Normal Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Biotest Human Normal Immunoglobulin Product
 Table 84. Biotest Recent Developments/Updates
 Table 85. Kedrion Company Information
 Table 86. Kedrion Description and Business Overview
 Table 87. Kedrion Human Normal Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Kedrion Human Normal Immunoglobulin Product
 Table 89. Kedrion Recent Developments/Updates
 Table 90. CBPO Company Information
 Table 91. CBPO Description and Business Overview
 Table 92. CBPO Human Normal Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. CBPO Human Normal Immunoglobulin Product
 Table 94. CBPO Recent Developments/Updates
 Table 95. Emergent (Cangene) Company Information
 Table 96. Emergent (Cangene) Description and Business Overview
 Table 97. Emergent (Cangene) Human Normal Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Emergent (Cangene) Human Normal Immunoglobulin Product
 Table 99. Emergent (Cangene) Recent Developments/Updates
 Table 100. Kamada Company Information
 Table 101. Kamada Description and Business Overview
 Table 102. Kamada Human Normal Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Kamada Human Normal Immunoglobulin Product
 Table 104. Kamada Recent Developments/Updates
 Table 105. CNBG Company Information
 Table 106. CNBG Description and Business Overview
 Table 107. CNBG Human Normal Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. CNBG Human Normal Immunoglobulin Product
 Table 109. CNBG Recent Developments/Updates
 Table 110. Hualan Bio Company Information
 Table 111. Hualan Bio Description and Business Overview
 Table 112. Hualan Bio Human Normal Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Hualan Bio Human Normal Immunoglobulin Product
 Table 114. Hualan Bio Recent Developments/Updates
 Table 115. Shanghai RAAS Company Information
 Table 116. Shanghai RAAS Description and Business Overview
 Table 117. Shanghai RAAS Human Normal Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Shanghai RAAS Human Normal Immunoglobulin Product
 Table 119. Shanghai RAAS Recent Developments/Updates
 Table 120. Sichuan Yuanda Shuyang Company Information
 Table 121. Sichuan Yuanda Shuyang Description and Business Overview
 Table 122. Sichuan Yuanda Shuyang Human Normal Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Sichuan Yuanda Shuyang Human Normal Immunoglobulin Product
 Table 124. Sichuan Yuanda Shuyang Recent Developments/Updates
 Table 125. ADMA Biologics Company Information
 Table 126. ADMA Biologics Description and Business Overview
 Table 127. ADMA Biologics Human Normal Immunoglobulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. ADMA Biologics Human Normal Immunoglobulin Product
 Table 129. ADMA Biologics Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Human Normal Immunoglobulin Distributors List
 Table 133. Human Normal Immunoglobulin Customers List
 Table 134. Human Normal Immunoglobulin Market Trends
 Table 135. Human Normal Immunoglobulin Market Drivers
 Table 136. Human Normal Immunoglobulin Market Challenges
 Table 137. Human Normal Immunoglobulin Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Human Normal Immunoglobulin
 Figure 2. Global Human Normal Immunoglobulin Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Human Normal Immunoglobulin Market Share by Type: 2024 & 2031
 Figure 4. Hepatitis B Immunoglobulins Product Picture
 Figure 5. Rabies Immunoglobulins Product Picture
 Figure 6. Tetanus Immunoglobulins Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Human Normal Immunoglobulin Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Human Normal Immunoglobulin Market Share by Application: 2024 & 2031
 Figure 10. Government Institutions
 Figure 11. Private Sector
 Figure 12. Other
 Figure 13. Global Human Normal Immunoglobulin Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Human Normal Immunoglobulin Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Human Normal Immunoglobulin Sales (2020-2031) & (K Units)
 Figure 16. Global Human Normal Immunoglobulin Average Price (US$/Unit) & (2020-2031)
 Figure 17. Human Normal Immunoglobulin Report Years Considered
 Figure 18. Human Normal Immunoglobulin Sales Share by Manufacturers in 2024
 Figure 19. Global Human Normal Immunoglobulin Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Human Normal Immunoglobulin Players: Market Share by Revenue in Human Normal Immunoglobulin in 2024
 Figure 21. Human Normal Immunoglobulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Human Normal Immunoglobulin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Human Normal Immunoglobulin Sales Market Share by Country (2020-2031)
 Figure 24. North America Human Normal Immunoglobulin Revenue Market Share by Country (2020-2031)
 Figure 25. U.S. Human Normal Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Human Normal Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Human Normal Immunoglobulin Sales Market Share by Country (2020-2031)
 Figure 28. Europe Human Normal Immunoglobulin Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Human Normal Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Human Normal Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Human Normal Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Human Normal Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Human Normal Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Human Normal Immunoglobulin Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Human Normal Immunoglobulin Revenue Market Share by Region (2020-2031)
 Figure 36. China Human Normal Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Human Normal Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Human Normal Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Human Normal Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Human Normal Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Taiwan Human Normal Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Indonesia Human Normal Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Thailand Human Normal Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Malaysia Human Normal Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Philippines Human Normal Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Human Normal Immunoglobulin Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Human Normal Immunoglobulin Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Human Normal Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Human Normal Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Human Normal Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Human Normal Immunoglobulin Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Human Normal Immunoglobulin Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Human Normal Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Human Normal Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. UAE Human Normal Immunoglobulin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Human Normal Immunoglobulin by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Human Normal Immunoglobulin by Type (2020-2031)
 Figure 58. Global Human Normal Immunoglobulin Price (US$/Unit) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Human Normal Immunoglobulin by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Human Normal Immunoglobulin by Application (2020-2031)
 Figure 61. Global Human Normal Immunoglobulin Price (US$/Unit) by Application (2020-2031)
 Figure 62. Human Normal Immunoglobulin Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Human Immunoglobulin pH4 for Intravenous Injection Market Research Report 2024
Global Human Immunoglobulin Market Research Report 2024
Global Human Immunoglobulin pH4 for Intravenous Injection COVID 19 Market Research Report 2024
Global Intravenous Immunoglobulin IVIg Market Research Report 2025
Global Human Hyperimmune Globulins Market Research Report 2024
Global Prophylactic Gamma Globulin Market Research Report 2024
Global Human Immumoglobulin PH4 for Intravenous Injection Market Insights Forecast to 2030
Global Hyperimmune Globulin Product Market Research Report 2024
Human Plasma derived Hyperimmune Product Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Human Plasma based Hyperimmune Preparation Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
IVIg Liquid Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hyperimmune Globulin Injection Market Research Report 2024
IVIg Powder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Tetanus Human Monoclonal Antibody Market Research Report 2024
Global Immunoglobulin G Antibody Therapeutics Market Insights Forecast to 2030
Human Gamma Globulin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hyper Immune Globulin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Plasma Protein Products Market Research Report 2024
Global Hyperimmune Globulins Market Research Report 2025
Human Immune Globulin Intravenous Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions